One small step for stool, one giant leap for IBD surveillance

Inflammatory bowel diseases (IBDs) are chronic conditions in which the digestive tract undergoes cycles of relapsing and remitting inflammatory episodes that cause patients to experience severe abdominal pain, bleeding, and diarrhea. Developing noninvasive and cost-effective surveillance methods tha...

Full description

Saved in:
Bibliographic Details
Published in:Tissue barriers 2024-02, p.2314839-2314839
Main Authors: Cohen, Dorrian G, Wingert, Rebecca A
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c257t-75022f6ba1648785e04ee5705cf43204435e7c10729fd22b127211ff39832a0d3
container_end_page 2314839
container_issue
container_start_page 2314839
container_title Tissue barriers
container_volume
creator Cohen, Dorrian G
Wingert, Rebecca A
description Inflammatory bowel diseases (IBDs) are chronic conditions in which the digestive tract undergoes cycles of relapsing and remitting inflammatory episodes that cause patients to experience severe abdominal pain, bleeding, and diarrhea. Developing noninvasive and cost-effective surveillance methods that can detect an ensuing disease bout proffers an avenue to improve the quality of life for patients with IBD. Now, a recent report describes an ingenious, economical approach using a rationally designed strain that can dynamically monitor inflammation inside the mammalian gastrointestinal tract. The ability of the engineered probiotic to specifically discern between dormant and activated inflammatory states of the digestive system demonstrates that living biosensors can be used to monitor health status, thus providing a powerful proof of concept that heralds the arrival of a new age of clinical diagnostics for people living with inflammatory diseases of the gut.
doi_str_mv 10.1080/21688370.2024.2314839
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2923909767</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2923909767</sourcerecordid><originalsourceid>FETCH-LOGICAL-c257t-75022f6ba1648785e04ee5705cf43204435e7c10729fd22b127211ff39832a0d3</originalsourceid><addsrcrecordid>eNpNkE1PwzAMhiMEYtPYTwD1yIEOx0ma9MABxtekSbvAOco6BxWl62haJP49rbYhfLHl1x-vHsYuOcw4GLhFnhkjNMwQUM5QcGlEfsLGQz8dhNN_9YhNY_yEPgxmoOU5GwkjUIOGMbtbbSmJlQshiS3tEl83fVHX4Sape-WjdNs2CeT2yuLhMYld801lCG5b0AU78y5Emh7yhL0_P73NX9Pl6mUxv1-mBSrdploBos_WjmfSaKMIJJHSoAovBYKUQpEuOGjM_QZxzVEj596LvPfpYCMm7Hp_d9fUXx3F1lZlLGgwQXUXLeYocsh1pvtRtR8tmjrGhrzdNWXlmh_LwQ7w7BGeHeDZA7x-7-rwoltXtPnbOqISvyy1Znc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2923909767</pqid></control><display><type>article</type><title>One small step for stool, one giant leap for IBD surveillance</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Cohen, Dorrian G ; Wingert, Rebecca A</creator><creatorcontrib>Cohen, Dorrian G ; Wingert, Rebecca A</creatorcontrib><description>Inflammatory bowel diseases (IBDs) are chronic conditions in which the digestive tract undergoes cycles of relapsing and remitting inflammatory episodes that cause patients to experience severe abdominal pain, bleeding, and diarrhea. Developing noninvasive and cost-effective surveillance methods that can detect an ensuing disease bout proffers an avenue to improve the quality of life for patients with IBD. Now, a recent report describes an ingenious, economical approach using a rationally designed strain that can dynamically monitor inflammation inside the mammalian gastrointestinal tract. The ability of the engineered probiotic to specifically discern between dormant and activated inflammatory states of the digestive system demonstrates that living biosensors can be used to monitor health status, thus providing a powerful proof of concept that heralds the arrival of a new age of clinical diagnostics for people living with inflammatory diseases of the gut.</description><identifier>ISSN: 2168-8370</identifier><identifier>EISSN: 2168-8370</identifier><identifier>DOI: 10.1080/21688370.2024.2314839</identifier><identifier>PMID: 38327070</identifier><language>eng</language><publisher>United States</publisher><ispartof>Tissue barriers, 2024-02, p.2314839-2314839</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c257t-75022f6ba1648785e04ee5705cf43204435e7c10729fd22b127211ff39832a0d3</cites><orcidid>0000-0003-3133-7549 ; 0009-0005-0546-5127</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38327070$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cohen, Dorrian G</creatorcontrib><creatorcontrib>Wingert, Rebecca A</creatorcontrib><title>One small step for stool, one giant leap for IBD surveillance</title><title>Tissue barriers</title><addtitle>Tissue Barriers</addtitle><description>Inflammatory bowel diseases (IBDs) are chronic conditions in which the digestive tract undergoes cycles of relapsing and remitting inflammatory episodes that cause patients to experience severe abdominal pain, bleeding, and diarrhea. Developing noninvasive and cost-effective surveillance methods that can detect an ensuing disease bout proffers an avenue to improve the quality of life for patients with IBD. Now, a recent report describes an ingenious, economical approach using a rationally designed strain that can dynamically monitor inflammation inside the mammalian gastrointestinal tract. The ability of the engineered probiotic to specifically discern between dormant and activated inflammatory states of the digestive system demonstrates that living biosensors can be used to monitor health status, thus providing a powerful proof of concept that heralds the arrival of a new age of clinical diagnostics for people living with inflammatory diseases of the gut.</description><issn>2168-8370</issn><issn>2168-8370</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkE1PwzAMhiMEYtPYTwD1yIEOx0ma9MABxtekSbvAOco6BxWl62haJP49rbYhfLHl1x-vHsYuOcw4GLhFnhkjNMwQUM5QcGlEfsLGQz8dhNN_9YhNY_yEPgxmoOU5GwkjUIOGMbtbbSmJlQshiS3tEl83fVHX4Sape-WjdNs2CeT2yuLhMYld801lCG5b0AU78y5Emh7yhL0_P73NX9Pl6mUxv1-mBSrdploBos_WjmfSaKMIJJHSoAovBYKUQpEuOGjM_QZxzVEj596LvPfpYCMm7Hp_d9fUXx3F1lZlLGgwQXUXLeYocsh1pvtRtR8tmjrGhrzdNWXlmh_LwQ7w7BGeHeDZA7x-7-rwoltXtPnbOqISvyy1Znc</recordid><startdate>20240207</startdate><enddate>20240207</enddate><creator>Cohen, Dorrian G</creator><creator>Wingert, Rebecca A</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3133-7549</orcidid><orcidid>https://orcid.org/0009-0005-0546-5127</orcidid></search><sort><creationdate>20240207</creationdate><title>One small step for stool, one giant leap for IBD surveillance</title><author>Cohen, Dorrian G ; Wingert, Rebecca A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c257t-75022f6ba1648785e04ee5705cf43204435e7c10729fd22b127211ff39832a0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cohen, Dorrian G</creatorcontrib><creatorcontrib>Wingert, Rebecca A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Tissue barriers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cohen, Dorrian G</au><au>Wingert, Rebecca A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>One small step for stool, one giant leap for IBD surveillance</atitle><jtitle>Tissue barriers</jtitle><addtitle>Tissue Barriers</addtitle><date>2024-02-07</date><risdate>2024</risdate><spage>2314839</spage><epage>2314839</epage><pages>2314839-2314839</pages><issn>2168-8370</issn><eissn>2168-8370</eissn><abstract>Inflammatory bowel diseases (IBDs) are chronic conditions in which the digestive tract undergoes cycles of relapsing and remitting inflammatory episodes that cause patients to experience severe abdominal pain, bleeding, and diarrhea. Developing noninvasive and cost-effective surveillance methods that can detect an ensuing disease bout proffers an avenue to improve the quality of life for patients with IBD. Now, a recent report describes an ingenious, economical approach using a rationally designed strain that can dynamically monitor inflammation inside the mammalian gastrointestinal tract. The ability of the engineered probiotic to specifically discern between dormant and activated inflammatory states of the digestive system demonstrates that living biosensors can be used to monitor health status, thus providing a powerful proof of concept that heralds the arrival of a new age of clinical diagnostics for people living with inflammatory diseases of the gut.</abstract><cop>United States</cop><pmid>38327070</pmid><doi>10.1080/21688370.2024.2314839</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3133-7549</orcidid><orcidid>https://orcid.org/0009-0005-0546-5127</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2168-8370
ispartof Tissue barriers, 2024-02, p.2314839-2314839
issn 2168-8370
2168-8370
language eng
recordid cdi_proquest_miscellaneous_2923909767
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
title One small step for stool, one giant leap for IBD surveillance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A40%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=One%20small%20step%20for%20stool,%20one%20giant%20leap%20for%20IBD%20surveillance&rft.jtitle=Tissue%20barriers&rft.au=Cohen,%20Dorrian%20G&rft.date=2024-02-07&rft.spage=2314839&rft.epage=2314839&rft.pages=2314839-2314839&rft.issn=2168-8370&rft.eissn=2168-8370&rft_id=info:doi/10.1080/21688370.2024.2314839&rft_dat=%3Cproquest_cross%3E2923909767%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c257t-75022f6ba1648785e04ee5705cf43204435e7c10729fd22b127211ff39832a0d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2923909767&rft_id=info:pmid/38327070&rfr_iscdi=true